✦ LIBER ✦

Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

✍ Scribed by Martinez-Trufero, J; Isla, D; Adansa, J C; Irigoyen, A; Hitt, R; Gil-Arnaiz, I; Lambea, J; Lecumberri, M J; Cruz, J J

Book ID: 110000489
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 306 KB
Volume: 102
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6605697

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of tgDCC-E1

A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

✍ Doug Villaret; Bonnie Glisson; Daniel Kenady; Ehab Hanna; Mary Carey; Lyon Gleic 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Background: The anti-cancer gene, e1a, can be complexed to a lipid carrier, dc-cholesterol:dope, to form tgdcc-e1a, which can be injected directly into tumors. ## Methods: Twenty-four patients with recurrent, unresectable, head and neck cancer were treated with intratumoral injections of tgdcc

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

A phase 2 study of pemetrexed plus gemci

A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer

✍ Matthew G. Fury; Sofia Haque; Hilda Stambuk; Ronglai Shen; Diane Carlson; David 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

Promising overall survival of patients w

Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study

✍ Muh-Hwa Yang; Peter Mu-Hsin Chang; Cheng-Hwai Tzeng; Shyue-Yih Chang; Pen-Yuan C 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 324 KB

Phase II study of capecitabine and cispl

Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy

✍ Kang, H J; Chang, H M; Kim, T W; Ryu, M-H; Sohn, H J; Yook, J H; Oh, S T; Kim, B 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 102 KB

Phase II study of weekly chemotherapy wi

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 330 KB